San Antonio Breast Cancer Symposium (SABCS) 2020

Texas 08 December 2020 - 12 December 2020

First-line ipatasertib-paclitaxel fails to show PFS benefit in PIK3CA/AKT1/PTEN-altered aTNBC

03 Feb 2021 by

Ipatasertib plus paclitaxel in the first-line setting does not confer a progression-free survival (PFS) benefit to patients with PIK3CA/AKT1/PTEN-altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC), according to a study presented at SABCS 2020.

First-line ipatasertib-paclitaxel fails to show PFS benefit in PIK3CA/AKT1/PTEN-altered aTNBC

03 Feb 2021

Adding chemo to endocrine therapy may benefit premenopausal women with early breast cancer

25 Jan 2021 by

The addition of chemotherapy to endocrine therapy improved invasive disease-free survival (IDFS) in premenopausal women with lymph node-positive early stage hormone receptor-positive (HR+) HER2-negative (HER2-) breast cancer with recurrence score ≤25, according to early results of the phase III SWOG S1007 RxPonder* trial presented at SABCS 2020. However, the benefits did not appear to extend to postmenopausal women.

Adding chemo to endocrine therapy may benefit premenopausal women with early breast cancer

25 Jan 2021

Breast cancer survivors less likely to get pregnant, but babies often healthy if they do

14 Jan 2021 by

While breast cancer survivors of childbearing age are less likely to get pregnant than the general population, most of them who do become pregnant deliver healthy babies without detrimental outcomes on their long-term survival, according to a large meta-analysis presented at the SABCS 2020 Congress.

Breast cancer survivors less likely to get pregnant, but babies often healthy if they do

14 Jan 2021

Physicians may underestimate symptoms in breast cancer patients undergoing radiotherapy

07 Jan 2021 by

Physicians may often underestimate symptoms of pain, oedema, fatigue, and pruritus in patients undergoing radiotherapy for breast cancer, according to a study presented at SABCS 2020.

Physicians may underestimate symptoms in breast cancer patients undergoing radiotherapy

07 Jan 2021

Omitting radiotherapy: An option after breast-conserving surgery in older patients?

29 Dec 2020 by

Omitting radiotherapy after breast-conserving surgery in older patients with hormone receptor (HR)-positive breast cancer who were also receiving appropriate systemic therapy did not impact overall survival (OS) at 10 years, even though the rate of local recurrence was higher than those who had radiotherapy, according to the PRIME* II study presented at SABCS 2020.

Omitting radiotherapy: An option after breast-conserving surgery in older patients?

29 Dec 2020

Yoga reduces depressive symptoms in young breast cancer survivors

20 Dec 2020 by

Behavioural interventions are effective in mitigating depressive symptoms in young survivors of breast cancer, according to a study presented at SABCS 2020. In particular, mindfulness meditation also improves other outcomes related to well-being such as fatigue and sleep disturbance.

Yoga reduces depressive symptoms in young breast cancer survivors

20 Dec 2020